C ell polarity is a fundamental characteristic of various cell types. Polarity is maintained by establishing an asymmetrical distribution of proteins at the plasma membrane. Cellular and tissue polarization is essential for processes, such as differentiation, cell division, junction formation, and migration. Three conserved multi-protein complexes have been identified to act as key polarity regulators in vertebrates and invertebrates: 1 the Par complex, the Crumbs complex, and the Scribble complex.
previously reported that Scrib is involved in endothelialdirected cell migration and is required for angiogenesis. 13 In particular, Scrib was involved in matrix signaling because it facilitates integrin α5 recycling to the plasma membrane and prevents its lysosomal degradation.
Integrins mediate cell-cell and cell-matrix interaction by binding ligands, such as fibronectin, vitronectin, collagen, and laminin. 14 Depending on the matrix type, the endothelial activity state is altered. Although collagen is associated with endothelial quiescence, fibronectin is typical for an active endothelium and is associated with inflammatory activation. These matrix constituents facilitate inflammatory signaling, and integrin-ligand crosstalk support endothelial response to cytokines. [15] [16] [17] [18] Based on our previous observation of an important role for Scrib in integrin α5 signaling, we hypothesize that the Scrib polarity protein promotes endothelial inflammatory signaling. To test this directly, we have examined cultured human endothelial cells and the systemic and local response of conditional tamoxifen-inducible endothelial-specific Scrib knockout mice.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Scrib Mediates Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Endothelial Cells
To assess the role of endothelial Scrib in inflammation processes, human umbilical vein endothelial cells (HUVEC) and human microvascular endothelial cells were transfected with small interfering RNAs (siRNAs) directed to Scrib or a control Scramble siRNA followed by stimulation with tumor necrosis factor (TNF)-α. Downregulation of Scrib led to a strong attenuation of the TNFα-stimulated vascular cell adhesion molecule-1 (VCAM-1) protein expression, but did not influence the intercellular adhesion molecule-1 (ICAM-1) protein abundance ( Figure 1A ; Figure IA in the online-only Data Supplement). As inflammatory signaling is often nonspecifically disturbed by siRNA and transfection, knockdown experiments were performed with small hairpin RNA (shRNA) directed against Scrib. VCAM-1 induction in response to TNFα but also interleukin (IL)-1β and lipopolysaccharide was similarly attenuated by Scrib shRNA, suggesting that the inhibitory effect of Scrib downregulation is independent of the type of inflammatory stimulus ( Figure 1B) . Similar effects were observed on VCAM-1 mRNA expression, indicating that the effects of Scrib were likely through transcriptional regulation of VCAM-1 rather than the level of VCAM-1 protein translation, trafficking, or stability ( Figure 1C ). Rescue experiments were performed with a Scrib-expression plasmid containing silent mutations rendering it resistant to the Scrib shRNA. Scrib overexpression had no effect of TNFα-induced VCAM-1 expression in control cells, but restored VCAM-1 expression in cells treated with Scrib shRNA ( Figure IB in the online-only Data Supplement). As we previously observed that integrin α5 is stabilized by Scrib 13 and as matrix impacts on endothelial inflammatory signaling, 19 we examined the relevance of these on the Scrib-dependent regulation of VCAM-1. Importantly, the anti-inflammatory effect of Scrib siRNA was matrix-independent, and downregulation of integrin α5 had no influence on TNFα-, IL1β-or lipopolysaccharide-induced VCAM-1 expression in HUVEC ( Figure IC and ID in the online-only Data Supplement). Thus, the effect of Scrib in cytokine-induced VCAM-1 expression is independent of the previously reported role of Scrib in integrin α5 sorting.
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VCAM-1 Expression Is Not Attenuated by Other Polarity Proteins
As Scrib is involved in endothelial planar cell polarity and apico-basal polarity of epithelial cells, the impact of other polarity proteins on the TNFα-induced VCAM-1 expression was examined. siRNA against lethal giant larvae homolog 2 did not influence the responses, whereas siRNA against discs large homolog 1 and Pals1-associated tight junction protein actually potentiated the TNFα-stimulated VCAM-1 expression ( Figure 2 ). Thus, the effect of Scrib in maintaining endothelial inflammatory response is specific for this particular polarity protein and suggests that it may not be related to Scrib's function in cellular polarity.
Scrib Is Not Involved in Classic Inflammatory Signaling
Because nuclear factor κ light chain enhancer of activated B-cells (NF-κB) is the main driver of VCAM-1 expression in endothelial cells, the impact of Scrib on this transcription factor was studied. Unexpectedly, Scrib shRNA had no effect on NF-κB expression, phosphorylation, or translocation, nor was the IκB level affected by downregulation of Scrib ( Figure 3A ; Figure II in the online-only Data Supplement). Similarly, TNFα-induced activation of the MAP kinases extracellular signal-regulated kinase-1/2, c-Jun N-terminal kinases, and p38 MAP kinase as well as of protein kinase B as studied by phospho-specific antibodies was not affected by Scrib downregulation ( Figure 3B ). As forkhead box (Fox)-O1 can also promote inflammatory signaling, 20 this transcription factor was studied next. Downregulation of Scrib slightly attenuated FoxO1 protein expression and translocation into the nucleus ( Figure IIIA in the online-only Data Supplement). Overexpression of FoxO1 or a constitutively active mutant of the transcription factor, however, failed to restore TNFα-stimulated VCAM-1 expression after Scrib shRNA ( Figure IIIB in the online-only Data Supplement). Furthermore, the FoxO1 inhibitor AS1842856 did not attenuate the TNFα-induced VCAM-1 induction ( Figure IIIC in the online-only Data Supplement). Thus, despite being slightly regulated by Scrib, FoxO1 is not the mediator of the anti-inflammatory effect of Scrib downregulation. Together these data demonstrate that the attenuated VCAM-1 induction in Scribdeficient cells is not a consequence of effects on classic inflammatory pathways.
GATA-Like Protein-1 Is an Interacting Partner of Scrib
In the search of potential other mediators of the effect of Scrib knockdown, we analyzed the VCAM-1 promoter. The promoter contains many GATA transcription factors-binding sites, and GATAs have previously been suggested to contribute to endothelial inflammatory signaling. 21 Because we recovered the similar nuclear zinc finger protein GATA-like protein-1 (GLP-1) in our previous interaction search ( Table  I in the online-only Data Supplement), 13 we focused on this protein.
Little is known about GLP-1, although it was reported to act as transcriptional repressor of GATA factor function in somatic cells of the gonads. 22 Its function in endothelial cells, however, is completely elusive. Importantly, we readily detected GLP-1 protein in HUVEC, human fibroblasts, human dermal microvascular endothelial cells, and human aortic smooth muscle cells ( Figure IVA in the online-only Data Supplement). Immunoprecipitation from the cytosolic fraction of HUVEC clearly identified Scrib as an interactor of GLP-1 ( Figure 4A ), and this interaction was also seen by proximity ligation assay ( Figure 4B ). In the few reports on GLP-1, the protein was considered a transcriptional repressor, 23 and thus, depletion of Scrib should result in higher GLP-1 level in the nucleus. In HUVEC, however, just the opposite was true: siRNA To test this aspect, chromatin immunoprecipitation experiments were performed. Indeed, it was possible to specifically recover elements of the VCAM-1 promoter by chromatin immunoprecipitation with an anti-GLP-1 antibody. Importantly, downregulation of Scrib reduced the recovered signal to the same extend as did downregulation of GLP-1. Thus Scrib, by limiting GLP-1 abundance, reduces the amount of this transcription factor binding to the VCAM-1 promoter ( Figure 4F ).
Scrib Mediates Leukocyte Adhesion In Vitro and In Vivo
To address the physiological relevance of the present findings, adhesion experiments were performed. First, the adhesion of freshly isolated human leukocytes to TNFα-stimulated HUVEC was studied. Downregulation of Scrib alone did not affect TNFα-induced leukocyte adhesion. As this might be a reflection of the fact that leukocytes can adhere to VCAM-1 and to ICAM-1 and as ICAM-1 expression was not controlled by Scrib, the experiments were repeated in the presence of an ICAM-1 blocking peptide. Importantly, in the presence of the peptide, leukocyte adhesion to Scrib-deficient endothelial cells was significantly attenuated ( Figure 5A ). To investigate whether these observations are also relevant in vivo, tamoxifen-induced endothelial-specific Scrib knockout mice were generated by crossing previously reported Scrib1-flox/flox mice 24 with Cdh5-CreERT2 mice. 25 By comparing intima and the remaining part of the carotid artery, effective tamoxifeninducible selective Scrib knockout in the endothelium could be proven on mRNA level ( Figure 5B ). Moreover, similar to the cultured HUVEC, GLP-1 protein was also significantly reduced in the intima of the Scrib-deficient mouse aortas ( Figure 5C ).
Next, in vivo lipopolysaccharide, as a global strong inflammatory stimulus, was used to induce vascular VCAM-1 and ICAM-1 systemically. Similarly as in cultured HUVEC, VCAM-1 mRNA induction was significantly attenuated in the intima of endothelial-specific Scrib knockout mice as compared with wild-type animals, whereas Scrib did not affect ICAM-1 expression ( Figure 5D ). As an approach to directly visualize leukocyte adhesion to the endothelium in vivo, we used intravital microscopy of the mouse cremaster muscle. Microvascular and hemodynamic parameters were similar between endothelial-specific Scrib knockout mice and wildtype controls (Table) . In addition, systemic leukocyte counts were not different between both groups (Table) . Similar to the in vitro observations, our in vivo study revealed that TNFαstimulated leukocyte adhesion in the cremaster muscle postcappillary venules of endothelial-specific Scrib-knockout mice was similar to that of the wild-type mice. However, after administration of the ICAM-1-blocking antibody YN1, leukocyte adhesion to Scrib-deficient endothelium was significantly reduced as compared with the endothelium of wild-type control mice ( Figure 5E ). These data identify Scrib as a facilitator of VCAM-1 induction in vivo and, therefore, as an important regulator of leukocyte adhesion.
Discussion
In the present study, we demonstrated that Scrib promotes cytokine-stimulated expression of VCAM-1. Loss of Scrib attenuated VCAM-1-dependent leukocyte adhesion ex vivo and in the mouse cremaster model. The effect of Scrib was mediated through changes in VCAM-1 mRNA because Scrib maintained the cellular level of GLP-1, a novel inducer of VCAM-1 expression.
Our previous studies revealed that Scrib is essential for recycling integrin α5 to the plasma membrane. 13 As fibronectin, the ligand of integrin α5, is a relatively proinflammatory matrix, 26 we speculated that Scrib may indirectly regulate the inflammatory response of endothelial cells. Although we found evidence in favor for this theory, the impact of Scrib on inflammatory signaling was different from our initial concept. Scrib does not seem to be involved in cytokine or matrix signaling of inflammation per se, but rather specifically contributed to VCAM-1 induction. In fact, the inflammatory responses to the classical stimuli TNFα, IL-1β, and lipopolysaccharide were not differentially affected by Scrib knockdown in cultured cells or in vivo. Rather, only the induction of VCAM-1 but not of ICAM-1 and E-selectin was affected by Scrib downregulation. Moreover, typical inflammatory pathways were totally independent of Scrib: cytokine-stimulated activation of NF-κB, the main driver for VCAM-1 and ICAM-1 expression, 27 was not affected by Scrib knockdown. Also protein kinase B and MAP kinase, such as p38, c-Jun N-terminal kinases, and extracellular signal-regulated kinase 1/2 activation, which all are involved in VCAM-1 and ICAM-1 induction, were independent of Scrib. 28 These findings were unexpected as was our observation that integrin α5 did not influence the endothelial response to cytokines. Scrib is a known interactor of the Rac GEF betaPIX. Rac not only elicit effects on the cytoskeleton, 29 but is also a main activator of NADPH oxidases of the Nox family. 30 In fact, inflammation is a main stimulus of Rac1 31 and of the NADPH oxidase, 32 and Nox activation has been shown to contribute to inflammatory signaling. 33 Despite this, we found no impact of Scrib on Nox activity (K. Pálfi, unpublished observations), and although we previously reported a role of Scrib on Rac1 localization within the cell, 13 this function seems to occur in a compartment unrelated to inflammatory signaling.
Based on this, it is tempting to speculate that the effect of Scrib is not a specific function of this polarity protein, but common to the whole family of polarity complex proteins. Unexpectedly, of all the polarity proteins we knocked down in the present study, only loss of Scrib elicited an anti-inflammatory effect, suggesting that Scrib is special as a polarity protein. Structurally, Scrib is mainly an adaptor protein carrying leucine-rich repeats and PDZ domains. Both domains are frequent in cells, and other proteins harboring them contribute to inflammatory signaling. For example, PDLIM2, a PDZ domain-containing nuclear protein, acts as an ubiquitin E3 ligase for the NF-κB subunit p65, 34 and the leucine-rich repeats protein LRRC33 inhibits NF-κB and AP-1 activation and cytokine production. 35 Pals1-associated tight junction protein of the Crumbs polarity complex, however, is also a PDZ protein and did not promote inflammatory signaling, suggesting that the underlying mechanism is more complex.
In the present study, we observed that Scrib affects cytokine-stimulated VCAM-1 mRNA expression similarly as it changed protein abundance. This excludes that Scrib contributes to VCAM-1 protein stability, trafficking, or sorting and leaves mRNA transcription and thus the promoter as the most probable targets of Scrib. Our promoter analyses indicated that although VCAM-1 and ICAM-1 share the NF-κB, AP-1, and PPARγ binding site in their promoter, important differences also exist: ICAM-1 also carries STAT-binding sites, whereas for VCAM-1 p300, FoxO1, FoxO3, FoxO4, GATA1, GATA2, and GATA3 sites can be identified. This may explain the differential regulation of VCAM-1 and ICAM-1 observed in this and other studies. 36, 37 It also supports our observation that AP-1 and NF-κB are not involved in the effect of Scrib as otherwise also ICAM-1 expression should be reduced after Scrib knockdown.
Our further analyses were focused on Fox protein transcription factors, which are present in the VCAM-1 promoter, and also previous studies have identified FoxO1 as a VCAM-1 promoter-binding protein. 20, 38 Indeed, Scrib was able to reduce FoxO1 in the nucleus of HUVEC, but against all odds, FoxO1 overexpression failed to rescue this effect. Moreover, inhibition of FoxO1 by an inhibitor did not alter VCAM-1 protein abundance in HUVEC.
This left GATA transcription factors as the most probable targets. The GATA family of transcription factors has 6 members as categorized by a DNA consensus sequence of 2 characteristic zinc-finger motifs. 39 Interestingly, many pathways controlling inflammation alter GATA factors like MAP kinases 40 or protein kinase B 41 and the phosphatase and tensin homolog system. 36 By reevaluation of our mass spectrometry data from Scrib immunoprecipitation, we found GLP-1 to be a Scrib-interacting protein. GLP-1 is reported as a nuclear protein containing 2 zinc fingers, one of which is highly homologous to the conserved GATA zinc finger DNA-binding motif. Forced expression of GLP-1 represses GATA in the activation of target promoters in Leydig cells of the testis and granulosa cells in the ovary. GLP-1(lacZ) null mice are infertile, caused by a marked reduction in oocyte development and severe sperm differentiation defects. 22, 23 Based on the similarity of GLP-1 and GATAs and on the fact that we recovered GLP-1 as Scrib-interacting protein, we focused on this factor. Scrib siRNA lowered the GLP-1 protein expression in the cytoplasm and in the nucleus. GLP-1 mRNA, in contrast, was not affected by Scrib knockdown, suggesting altered translation efficiency or protein stability. Using different inhibitors, we failed to obtain support for the latter aspect, but the experiments were technically difficult because low protein abundance and limited antibody quality (K. Pálfi, unpublished data). Additional experiments will be required to ultimately clarify this point. Because Scrib seems to maintain GLP-1 protein expression, it should allow sufficient GLP-1 to enter the nucleus and to promote VCAM-1 gene expression. Indeed, chromatin immunoprecipitation experiments demonstrated that GLP-1 binds the VCAM-1 promoter, and this effect was not only reduced by siRNA against GLP-1 but also against Scrib. Although silencing of Scrib limited VCAM-1 expression to a physiologically important extent, the contribution of Scrib to VCAM-1 expression was somewhat modest. Given that classic inflammatory signaling through NF-κB was Scrib-independent, this was expected. Interestingly, however, downregulation of GLP-1 and of Scrib yielded a similar reduction of VCAM-1 expression. This might suggest that the effect of Scrib specifically involves GLP-1.
ICAM-1 and VCAM-1 promote the adhesion of lymphocytes, monocytes, and granulocytes to the activated endothelium by establishing strong bonds with integrins. Inhibition or loss of one or more of the members of the immunoglobulin superfamily decreases leukocyte adhesion and migration. [42] [43] [44] In our hands, adhesion experiments of leukocytes to inflamed HUVEC showed similar effects in Scrib-deficient cells, however, only after blocking of ICAM-1, suggesting that ICAM-1 functionally compensates the lack of VCAM-1 expression. Consistent with our in vitro data, inducible endothelialspecific Scrib knockout mice exhibit a reduced VCAM-1 mRNA expression in the endothelium of carotid arteries. Furthermore, in vivo microscopy experiments clearly demonstrated that the leukocyte adhesion after ICAM-1 inhibition is attenuated. Despite the fact that adhesion of leukocytes is mediated by ICAM-1 and VCAM-1, the latter adhesion molecule is not dispensable: Genetic deletion of VCAM-1 results in embryonic lethality as a result of placenta malformation. 45 Also immune responses are dependent on VCAM-1 because, for example, infection with toxoplasms cannot be controlled after VCAM-1 deletion in mice. 46 Importantly, VCAM-1 has a central role in early atherosclerosis development 47 and in the inflammatory response after myocardial infarction. 48 VCAM-1 but not ICAM-1 deficiency reduces atherosclerotic development in Ldlr -/mice. 49 ApoE(−/−) knockout mice, lacking the VCAM-1 D4D allele, have clearly reduced arterial VCAM-1 expression, monocyte adherence in the aortic root, and fatty streak formation. 50 A recent study also demonstrated that an anti-VCAM-1 antibody markedly reduced adhesion of inflammatory cells in ApoE(−/−) mice with a subsequent attenuation of atherosclerosis development. 51 Thus, although ICAM-1 and VCAM-1 are both increased in inflammation and promote adhesion of white blood cell, they are not merely redundant in their function. In fact, VCAM-1 is an attractive mediator of inflammation-driven atherosclerosis. Thus, considering that Scrib selectively interferes with VCAM-1, inhibition at Scrib might be a strategy to attenuate atherosclerosis development.
In summary, with this study, we identified GLP-1 as a novel interaction partner of Scrib controlling inflammatory response. Scrib indirectly maintains VCAM-1 expression, and by this it alters the cytokine-induced leukocyte adhesion to the endothelium.
